Conference abstractPublished 25 May 2017
The ginsenoside, Rh2, induces apoptosis in endometrial cancer cells
Seoul National University Bundang Hospital, South Korea
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The ginsenoside-Rh2 has been found to inhibit the growth of many types of cancer cells. However, the effect of Rh2 on the growth of endometrial cancer cells has not been investigated. In this study, to determine the anticancer effect of Rh2 in endometrial cancer and to elucidate the mechanism underlying this effect, we investigated the effects of Rh2 on the cell proliferation and epithelialâÂ?Â? mesenchymal transition (EMT) in the human endometrial cancer cell lines, HEC1A and Ishikawa. We found that Rh2 inhibited cell proliferation and significantly induced apoptosis. The levels of cleaved poly ADP ribose polymerase (PARP) and cleaved caspase-3 were significantly increased in the HEC1A and Ishikawa cells treated with Rh2, indicating that Rh2 clearly suppressed the growth of HEC1A and Ishikawa cells in vitro. We also confirmed the apoptotic effects of Rh2, using terminal deoxynucleotidyltransferasemediated digoxigenin-dUTP-biotin nick end labeling (TUNEL) assay. Next, we investigated the effect of Rh2 on EMT in the HEC1A cell line. Rh2 treatment increased E-cadherin expression and decreased vimentin, TGF-Ã?² and Snail expression in the cells. Moreover, the migration assay results showed that Rh2 inhibited the migration of HEC1A cells and the invasion assay performed using Matrigel showed that Rh2 inhibited the invasive ability of HEC1A cells. Taken together, our results suggest that Rh2 exerts anticancer effects in endometrial cancer cells through the induction of apoptosis and inhibition of EMT.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Yong Beom Kim”
